At a tissue specific level, abdominal SAT in patients with NASH was severely insulin resistant, requiring >sixfold more insulin to cause 1⁄2-maximal suppression of glycerol release when compared with healthy controls. Here, INS is linked to metabolic dysfunction-associated steatohepatitis.